New insulin pump study for children with new type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study tests a new insulin pump system (MiniMed 780G) in children aged 7-17 who were recently diagnosed with type 1 diabetes. It aims to see if this pump helps control blood sugar better and improves quality of life compared to standard insulin shots or older pumps.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 7 to 17 years old.
- You have been recently diagnosed with type 1 diabetes.
- You use at least 8 units of insulin per day over a week.
- You can read Greek or English.
- You have internet access at home to download pump data.
- You are willing to wear the pump and follow study instructions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether following a Mediterranean diet can improve blood sugar control and insulin use in people with type 1 diabetes who are starting a new insulin pump (MiniMed 780G). It compares how diet affects glucose levels and insulin needs.
This trial studies how the Medtronic 780G “closed-loop” insulin system works for young people with type 1 diabetes. It may help by improving how automatically insulin is delivered, depending on your body’s needs.
This study tests a new automated insulin delivery system (a pump that helps manage blood sugar) in children and adults with diabetes. It aims to see if the system is safe and easy to use in daily life.
This study tests a new experimental automated insulin delivery system for people with type 1 or type 2 diabetes who already use a specific insulin pump (MiniMed 780G with Simplera Sync sensor). The goal is to see if the new system is safe and works well to help manage blood sugar.
This study tests a new automated insulin delivery system to help people with type 1 diabetes better manage their blood sugar. It aims to see if the system improves glucose control safely.
This study tests a new automated insulin delivery (AID) system that connects your insulin pump to your glucose monitor to help keep your blood sugar in range. It is for both children and adults with type 1 diabetes who have not used an AID system before.
Hear when a new Diabetes Mellitus, Type I trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.